Clinical Trials

Syngene: Is the worst of worries priced in?

The company is working on growth levers, such as expanding biologics manufacturing in Bengaluru, investing in clinical capabilities for peptides, and foraying into clinical trials opportunity.

Glenmark shares rally over 2.5 percent on muti-nation Phase 3 trial for cancer drug Envafolimab

An exchange filing by Glenmark said that it has received approval from the Drugs Controller General of India (DCGI) to commence patient enrollment and dosing in India.

Ask ChatGPT if you are eligible for a clinical trial: It may help speed up the screening process, study finds

Researchers used GPT-3.5 and GPT-4, trying three ways to guide the model. The most effective version, GPT-4, gave more accurate results but took slightly more time and cost.

Symptoms of depression are more common than you think, here’s how to spot the early signs

Signs and symptoms of depression: Extreme sadness, lack of interest, sleeessness, are all signs of poor mental health. Depression doesn’t look the same for everyone, but it’s affecting millions, and it’s growing, says a recent report by CDC. Here is what you should know.

Do you crave sugary drinks? Study reveals its connection with depression

Causes of depression: A new research, conducted by scientists at Wenzhou Medical University in China, has confirmed how different beverages impact mental health. Sugary drinks and beverages containing artificial sweeteners may increase the risk of depression.

More the screen exposure in children, higher the depressive symptoms, study reveals

As children continue to grow up in a digital age, parents and educators must take proactive steps to limit excessive screen use and encourage more active lifestyles.

What is double depression: Symptoms, causes and treatment

Unlike standalone MDD, where depressive episodes come and go, or PDD, which lingers at a lower intensity, double depression traps individuals in an unrelenting cycle. Here's what you need to know

Wockhardt shares up 10% after Zaynich achieves 96.8% efficacy in Phase III study

Wockhardt's Zaynich, an investigational antibiotic, has been under evaluation for its efficacy in treating complicated urinary tract infections.

Causes, symptoms and cure for Seasonal Affective Disorder (SAD)

Most people with Seasonal Affective Disorder experience symptoms that start in the fall and continue into the winter months, sapping their energy and making them feel moody. These symptoms usually resolve during the spring and summer months. Here are its causes, symptoms and treatment.

Feeling sad? Here's how high cortisol level weakens immunity, makes you prone to illnesses

Did you know that your emotions are closely linked to your immune system? Both happiness and sadness can affect your health in various ways. By focusing on your emotional well-being, you can help prevent a range of illnesses.

Elon Musk envisions widespread adoption of Neuralink technology: "Hundreds in coming years, millions in a decade"

“If all goes well, there will be hundreds of people with Neuralinks within a few years, maybe tens of thousands within 5 years, millions within 10 years,” Musk wrote on X.

Bengaluru's first double-decker flyover will open for 'trial runs' tomorrow

The construction of the double-decker flyover stretching from Ragigudda to Central Silk Board (3.3 km) was completed last month.

Wockhardt hopes to complete Phase III trials for Zaynich by Q1 of 2025

So far it has supplied the compound to 30 patients for compassionate use with range of life-threatening infections

Elon Musk’s Neuralink assures that the 'malfuntion' in brain implant is fixed

Noland Arbaugh, Neuralink’s first human test subject, had a brain implant in January but developed a problem just a few weeks after

Veeda Clinical Research: CX Partners-led consortium looks to sell majority stake, eyes $600 mn -$650 mn valuation

In December 2018, a consortium of growth-oriented private equity firms led by CX Partners acquired a 'significant' equity ownership in Veeda.

Signs that you may be suffering with High-Functioning Depression

Causes, symptoms and treatment of High functioning depression: Despite its less apparent nature, HFD can profoundly impact an individual's life, often slipping under the radar of both the person experiencing it and those around them. Watch out for these warning signs which will help you cope with the situation.

CX Partners-backed Veeda Clinical Research appoints Mahesh Bhalgat as Group CEO

In November 2018, a consortium of private equity investors led by CX Partners acquired a significant equity ownership in Veeda Clinical Research.

Union ayush and health ministers to announce multi-centre clinical trial on anaemia

It will be carried out at eight different sites -- MGIMS-Wardha, AIIMS-Jodhpur, NITM-Bengaluru, RIMS-Ranchi, KEM Hospital Research Centre, AIIMS-New Delhi, AIIMS-Bhopal and AIIMS-Bibinagar -- the statement said.

Oxford scientists launch first human vaccine trials for deadly Nipah virus

The trials of the ChAdOx1 NipahB vaccine, consisting of 51 people aged 18 to 55, will be led by the Oxford Vaccine Group.

Wockhardt has more antibiotics in the pipeline: Dr Habil Khorakiwala

Wockhardt could be more of a research company in five years than what it is today.

Karnataka revised biotech policy: Investment subsidy of upto Rs 10 cr; biofoundries in PPP mode

Karnataka biotechnology draft policy offers investment subsidy of upto 10 crore; fellowship of Rs 50,000 per month for 12 months to graduating students or professionals with experience

Musk's Neuralink to start human trial of brain implant for paralysis patients

Those with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis may qualify for the study, it said, but did not reveal how many participants would be enrolled in the trial, which will take about six years to complete.

Protest against Asian Games trials exemption reaches the IOA doors

Around 150 people, including family members of the wrestlers, are seeking a meeting with Indian Olympic Association (IOA) President P T Usha and ad-hoc panel chief Bhupender Singh Bajwa.